MedTrace Logo

AneuFix - Prophylactic Sac Filling

NCT04307992 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2024-06-07

No results posted yet for this study

Summary

This study is set up to assess the feasibility and safety of the clinical procedure using AneuFix in a prophylactic setting at the time of EVAR endograft implantation.

Conditions

  • Abdominal Aortic Aneurysm
  • Endoleak

Interventions

DEVICE

Prophylactic sac filling with AneuFix

ANEUFIX is administered by injection into the AAA via transferal access at the time of EVAR placement using imaging techniques to guide the place of injection.

Sponsors & Collaborators

  • TripleMed B.V.

    lead INDUSTRY

Principal Investigators

  • Arjan WJ Hoksbergen, Dr · VUmc Heelkunde, Amsterdam

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-15
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04307992 on ClinicalTrials.gov